XTLB
Xtl Biopharmaceuticals·NASDAQ
--
--(--)
--
--(--)
7.33 / 10
Outperform
Fund flow evaluation: 7.33/10 reflecting robust fund flow characteristics. Constructive Small, Medium, and Large trends face headwinds from adverse overall, block, and Extra-large developments, indicating positive money flow direction.
Fund Flow Rating
Is money flowing into or out of XTLB?
- XTLB holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.33/10 (Outperform).
